Supplementary Figure 1.
Verification of 3 selected NYTA up-regulated multicancer genes. Q-RT-PCR data was normalized using s18 levels. The corresponding COGENT analysis for these genes is presented in Supplementary Table 5 . DNET: Dysembryoplastic neuroepithelial tumour Figure 3 in the main article: The number of cancer types in which a gene is differentially expressed (multi-cancerness) explains several properties of genes A) Under-expressed multi-cancer genes are not enriched for cancer geneRIFs. X axis indicates gene sets which are altered more than a certain number of cancer types. Y axis indicates either FDR percentage or p value of the geneRIF enrichment. Genes which are common to all platforms are used in the analysis. B) Same type of analysis as in Figure 3B for under-expressed genes: Rank of a gene's expression change decreases with its being multi-cancer (the minimum rank of a gene was considered when multiple probesets are mapping to a single gene; the dataset is sorted by p value for microarray data and first by p value and then fold value for SAGE data). T value is Kendall Tau B correlation coefficient between X axis values and means of each subgroup in the Y axis (p = 5.69e-5). Highly significant but smaller correlation exists when all data points rather than means are considered (T = -0.090, p < 1.3e-43). Genes which are common to all platforms are used in the analysis. The expected distributions in B and D are the randomly shuffled versions of the observed values to control for the within group sample size effect, if any. C) Same type of analysis as in Figure 3C for over-expressed genes: Rank of a gene's expression change in a single cancer type explains being associated to cancer. Ranks of the tumour-associated and not yet tumour-associated genes are significantly different for half of the X axis values (# of cancer types), and when the data is not sub-divided by the X axis (p < 0.000000, Mann Whitney U test; data not shown). All genes are used in the analysis. D) Same type of analysis as in Figure 3D for under-expressed genes: Under-expressed multi-cancer genes have lower number of orthologs (homologs in different species). T value is Kendall Tau B correlation coefficient between X axis values and means of each subgroup on the Y axis (p = 0.025). Significant but smaller correlation exist when all data points rather than means are considered (T = -0.06, p = 7.4e-6). Genes which are common to all platforms are used in the analysis. ***: p value < 0.005, **: p value < 0.01, *: p value < 0.05. p values are of two independent samples ttest. In all of the graphs, the point markers are means of the data, and the error bars indicate standard error. Figure 3 . Determination of appropriate window size for TA-RIDGEs. A) Number of RIDGEs with varying minimum gene count thresholds; detected by using the ICEBERG algorithm with a primary p value cutoff of 0.002 and secondary p value of 0.05. B) Number of genes reach a plateau around 20-25. We selected 21 as the minimum window size that gives as much information as larger window sizes. Figure 4 . Distributions of family gene %, normal co-regulation % and peaking gene % among TA-RIDGEs and NA-RIDGEs. A) Family gene (a gene which has at least one family member within the same RIDGE) density over all TA-RIDGEs. B) Peaking gene (a gene identified to be significantly co-regulated with its neighbours) density calculated as the ratio of peaking genes / all genes in the spanned genomic region. C) and D) are family gene and peaking gene distributions for NA-RIDGEs. E) Normal co-regulation % distribution among all TA-RIDGEs. Normal co-regulation % is the percentage of genes at a TA-RIDGE that score above the p=0.05 threshold in the corresponding region from the normal tissue matrix). F) Normal co-regulation % distribution among TA-RIDGEs which have 10 or more genes (genes which were detected as members of the RIDGE and significantly co-regulated; not genes in the whole RIDGE region). Figure 5 . Metallothionein TA-RIDGE: Each coloured box represents differential expression with the merged COGENT dataset (Q value < 0.05 for microarray, p value < 0.02 for SAGE). Cross-dashed boxes represent missing data. Cancers are sorted by the fold enrichment of differential expression over the expected random differential expression, as explained in Supplementary Methods. Fold enrichment values are stated in parantheses beside the tumour names. Only cancers that are significantly (p < 0.01) represented are shown. The arcs between rows represent significant (red arcs < p = 0.001 < black arcs < p = 0.002) co-differential expression events. Figure 6 . Histone 1 TA-RIDGE: Each coloured box represents differential expression with the merged COGENT dataset (q value < 0.05 for microarray, p value < 0.02 for SAGE). Crossdashed boxes represent missing data. Cancers are sorted by the fold enrichment of differential expression over the expected random differential expression, as explained in Supplementary Methods. Fold enrichment values are stated in parantheses beside the tumour names. Only cancers that are significantly (p < 0.01) represented are shown. The arcs between rows represent significant (red arcs < p = 0.001 < black arcs < p = 0.002) co-differential expression events. Figure 7 . MHC Class II TA-RIDGE: Each coloured box represents differential expression with the merged COGENT dataset (q value < 0.05 for microarray, p value < 0.02 for SAGE). Cross-dashed boxes represent missing data. Cancers are sorted by the fold enrichment of differential expression over the expected random differential expression, as explained in Supplementary Methods. Fold enrichment values are stated in parantheses beside the tumour names. Only cancers that are significantly (p < 0.01) represented are shown. The arcs between rows represent significant (red arcs < p = 0.001 < black arcs < p = 0.002) co-differential expression events. Figure 8 . Chr8_NAPRT1: An example of a GC rich non-paralog TA-RIDGE where genes are differentially expressed in a wide variety of tumours. Upper: Green dots indicate genomic GC content of the gene; dark yellow dots indicate neighbourhood co-regulation score. Lower: Each colored box represents differential expression with the merged COGENT dataset (q value < 0.05 for microarray, p value < 0.02 for SAGE). Cross-dashed boxes represent missing data. Cancers are sorted by the fold enrichment of differential expression over the expected random differential expression, as explained in Supplementary Methods. Fold enrichment values are stated in parantheses beside the tumour names. Only cancers that are significantly (p < 0.01) represented are shown. The arcs between rows represents significant (p < 0.002) co-differential expression events. Figure 9 . Distributions of C/G bases and CG/GC base pairs significantly differ in RIDGEs vs. non-RIDGEs. Promoters or whole genomic region of genes in non-paralog TA-RIDGE have significantly more GC/CG pairs (promoters -(A); genomic regions -(B)) or C/G bases (promoters -(C); genomic regions -(D)) when compared to all TA-RIDGEs, NA-RIDGEs or non-paralog RIDGEs of a window size of 27. All TA-RIDGEs and NA-RIDGEs are also more G/C and GC/CG rich than non-RIDGEs except for the promoter CG/GC distribution (A). In all box and whisker plots, boxes span lower and upper quartiles whereas whiskers span 1.5 times inter-quartile range; red lines indicate median. On the Y axis, numbers in parentheses show number of genes. The blue lines indicate significance of the difference; thicker lines being more significant differences. To exemplify the scale; smallest and largest p values after the initial p value filter (p < 0.01) are indicated by arrows. Supplementary Table 1 . Tumour types used in the meta-analysis and two different classifications as used in www.oncoreveal.org
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Major Supplementary Table 5 . COGENT-SAGE analysis by using www.oncoreveal.org for the genes examined by RT-PCR or Q-RT-PCR (presented at Figure 2 of the main article) Supplementary Table 6B . FDR percentage and geneRIF enrichment probabilities for varying cancer type thresholds. Tabular version of the data presented in Figure 3A and Supplementary Figure 2A . 13 0,47 0,053312 0,015251 0,00 0,544079 0,04523 14 0,00 0,005942 0,022846 0,00 0,466105 0,056481 15 0,00 0,002469 0,033325 0,00 0,594979 0,02909 * FDR % is the expected ratio of false positives to observed significant changes. ** p values are of ranksums test. Supplementary Table 7A . Already well established TA multi cancer genes. All data was filtered for the genes for which expression is altered (up or down) in more than 10 types of tumours when compared to corresponding normals. Genes are sorted by number of cancer geneRIFs in descending order.
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